Listing 1 - 10 of 69 | << page >> |
Sort by
|
Choose an application
This panel discussion addresses the Ebola crisis in West Africa and how the crisis has already had a profound impact on millions of people in Guinea, Liberia, and Sierra Leone. Participants discussed the urgent issues that must be handled, including urgent financing.
Choose an application
AIDS (Disease) --- AIDS (Disease) --- Slow Virus Diseases --- HIV Infections --- Lentivirus Infections --- Virus Diseases --- Immunologic Deficiency Syndromes --- Sexually Transmitted Diseases, Viral --- Sexually Transmitted Diseases --- Immune System Diseases --- Retroviridae Infections --- Diseases --- RNA Virus Infections --- Acquired Immunodeficiency Syndrome --- Prevention --- Economic aspects --- World Bank.
Choose an application
Reliable evidence on the results of investments at the community level is in short supply. While communities have played a large role in the HIV/AIDS response, their contributions and innovative approaches to HIV prevention, treatment, care and support have not always been the focus of systematic and rigorous evaluations. To address this gap, seventeen analytical pieces were undertaken including evaluations in Burkina Faso, India, Kenya, Lesotho, Nigeria, Senegal, South Africa and Zimbabwe over a three -year period (early 2009 to early 2012) to build a robust pool of evidence on the effects of
AIDS (Disease) --- HIV (Viruses) --- Outcome assessment (Medical care) --- Prevention. --- Assessment of outcome (Medical care) --- Outcome evaluation (Medical care) --- Outcome measures (Medical care) --- Outcomes assessment (Medical care) --- Outcomes measurement (Medical care) --- Outcomes research (Medical care) --- Patient outcome assessment --- AIDS-associated retrovirus --- AIDS virus --- ARV (Viruses) --- HTLV-III (Viruses) --- HTLV-III-LAV (Viruses) --- Human immunodeficiency viruses --- Human T-cell leukemia virus III --- Human T-cell lymphotropic virus III --- Human T-lymphotropic virus III --- IDAV (Viruses) --- Immunodeficiency-associated virus --- LAV (Viruses) --- LAV-HTLV-III (Viruses) --- Lymphadenopathy-associated virus --- T-lymphotrophic virus III, Human --- Medical care --- HTLV (Viruses) --- Virus-induced immunosuppression --- Evaluation
Choose an application
Addresses the challenge of enabling the development of viable, resilient, and fiscally sustainable health system in Guinea, Liberia, and Sierra Leone. Initiated while Ebola was still raging in all of the three most-affected countries in West Africa, the study identifies the requirements for strengthening the health systems in these countries to go beyond just getting the number of Ebola cases to zero. The overall goal of this study is thus twofold: To assess the capacity of the health systems of the three most-affected countries in terms of their ability to deliver quality health services to their populations, perform core public health functions on a routine basis, and to respond to public health emergencies; and To identify the highest impact strategies to help these countries to strengthen their health systems to be more effective and resilient, drilling down into three key aspects of the health system-- that is, fiscal space for universal health coverage (UHC), development and deployment of an effective health workforce, and continuous disease surveillance.--
Ebola virus disease. --- Medical care --- 2000-2099 --- Africa, Western. --- Africa. --- Africa, West.
Choose an application
Tuberculosis --- AIDS (Disease) --- Lentivirus Infections --- Immunologic Deficiency Syndromes --- Sexually Transmitted Diseases, Viral --- Mycobacterium Infections --- Slow Virus Diseases --- Retroviridae Infections --- Actinomycetales Infections --- Immune System Diseases --- Virus Diseases --- Sexually Transmitted Diseases --- RNA Virus Infections --- Gram-Positive Bacterial Infections --- Diseases --- Bacterial Infections --- Bacterial Infections and Mycoses --- Acquired Immunodeficiency Syndrome --- HIV Infections
Choose an application
The 1992 creation of the National HIV/AIDS Program was a fundamental step for Argentina to reach the second lowest burden of HIV/AIDS in South America. From 2000 to 2010, Argentina further reduced the already low HIV/AIDS incidence of 15.9 per 100,000 by 25 percent and reduced the burden by 21 percent. This study analyzes the national and inter-provincial burden of disease, the demographics of new HIV cases, the demand and supply-sides of service delivery, and conducts a cost-benefit analysis of the National HIV/AIDS Program over the last decade. Though the National HIV/AIDS Program was an ins
AIDS (Disease) -- Argentina -- Epidemiology. --- HIV infections -- Argentina. --- Medicine. --- AIDS (Disease) --- HIV infections --- Sexually Transmitted Diseases, Viral --- Immunologic Deficiency Syndromes --- Lentivirus Infections --- Slow Virus Diseases --- Retroviridae Infections --- Sexually Transmitted Diseases --- Immune System Diseases --- Virus Diseases --- Diseases --- RNA Virus Infections --- Acquired Immunodeficiency Syndrome --- HIV Infections --- Public Health --- Health & Biological Sciences --- Communicable Diseases --- Epidemiology --- Argentina --- HTLV-III Infections --- HTLV-III-LAV Infections --- T-Lymphotropic Virus Type III Infections, Human --- HIV Infection --- HTLV III Infections --- HTLV III LAV Infections --- HTLV-III Infection --- HTLV-III-LAV Infection --- Infection, HIV --- Infection, HTLV-III --- Infection, HTLV-III-LAV --- Infections, HIV --- Infections, HTLV-III --- Infections, HTLV-III-LAV --- T Lymphotropic Virus Type III Infections, Human --- Acquired Immune Deficiency Syndrome --- Acquired Immuno-Deficiency Syndrome --- AIDS --- Immunodeficiency Syndrome, Acquired --- Immunologic Deficiency Syndrome, Acquired --- Acquired Immuno Deficiency Syndrome --- Acquired Immuno-Deficiency Syndromes --- Acquired Immunodeficiency Syndromes --- Immuno-Deficiency Syndrome, Acquired --- Immuno-Deficiency Syndromes, Acquired --- Immunodeficiency Syndromes, Acquired --- Syndrome, Acquired Immuno-Deficiency --- Syndrome, Acquired Immunodeficiency --- Syndromes, Acquired Immuno-Deficiency --- Syndromes, Acquired Immunodeficiency --- Infections, RNA Virus --- Infection, RNA Virus --- RNA Virus Infection --- Virus Infection, RNA --- Virus Infections, RNA --- Viral Diseases --- Viral Infections --- Virus Infections --- Disease, Viral --- Disease, Virus --- Diseases, Viral --- Diseases, Virus --- Infection, Viral --- Infection, Virus --- Infections, Viral --- Infections, Virus --- Viral Disease --- Viral Infection --- Virus Disease --- Virus Infection --- Diseases of Immune System --- Immune Diseases --- Immunological Diseases --- Immune Disorders --- Immunologic Diseases --- Disease, Immune --- Disease, Immune System --- Disease, Immunologic --- Disease, Immunological --- Diseases, Immune --- Diseases, Immune System --- Diseases, Immunologic --- Diseases, Immunological --- Disorder, Immune --- Disorders, Immune --- Immune Disease --- Immune Disorder --- Immune System Disease --- Immunologic Disease --- Immunological Disease --- STDs --- STIs --- Sexually Transmitted Infections --- Venereal Diseases --- Disease, Sexually Transmitted --- Disease, Venereal --- Diseases, Sexually Transmitted --- Diseases, Venereal --- Infection, Sexually Transmitted --- Infections, Sexually Transmitted --- STI --- Sexually Transmitted Disease --- Sexually Transmitted Infection --- Transmitted Infection, Sexually --- Transmitted Infections, Sexually --- Venereal Disease --- Infections, Retroviridae --- Infections, Retrovirus --- Retrovirus Infections --- Infection, Retroviridae --- Infection, Retrovirus --- Retroviridae Infection --- Retrovirus Infection --- Disease, Slow Virus --- Diseases, Slow Virus --- Slow Virus Disease --- Virus Disease, Slow --- Virus Diseases, Slow --- Infections, Lentivirus --- Infection, Lentivirus --- Lentivirus Infection --- Deficiency Syndrome, Immunologic --- Deficiency Syndromes, Antibody --- Deficiency Syndromes, Immunologic --- Immunologic Deficiency Syndrome --- Immunological Deficiency Syndromes --- Antibody Deficiency Syndrome --- Antibody Deficiency Syndromes --- Deficiency Syndrome, Antibody --- Deficiency Syndrome, Immunological --- Deficiency Syndromes, Immunological --- Immunological Deficiency Syndrome --- Syndrome, Antibody Deficiency --- Syndrome, Immunologic Deficiency --- Syndrome, Immunological Deficiency --- Syndromes, Antibody Deficiency --- Syndromes, Immunologic Deficiency --- Syndromes, Immunological Deficiency --- Antibodies --- Sexually Transmitted Disease, Viral --- Viral Sexually Transmitted Disease --- Viral Sexually Transmitted Diseases --- Viral Venereal Diseases --- Venereal Diseases, Viral --- Disease, Viral Venereal --- Diseases, Viral Venereal --- Venereal Disease, Viral --- Viral Venereal Disease --- HIV (Viruses) infections --- HTLV-III infections --- HTLV-III-LAV infections --- Human T-lymphotropic virus III infections --- Acquired immune deficiency syndrome --- Acquired immunodeficiency syndrome --- Acquired immunological deficiency syndrome --- deficiency --- HIV Coinfection --- Coinfection, HIV --- Coinfections, HIV --- HIV Coinfections --- CD4-Positive T-Lymphocytes --- HIV-1 --- AIDS Arteritis, Central Nervous System --- Venereology --- Reproductive Tract Infections --- XMRV Infection --- Xenotropic MuLV-related Virus Infection --- Xenotropic Murine Leukemia Virus-related Virus Infection --- Infection, XMRV --- Infections, XMRV --- XMRV Infections --- Xenotropic MuLV related Virus Infection --- Xenotropic Murine Leukemia Virus related Virus Infection --- Lentivirus infections --- Sexually transmitted diseases --- Immunological deficiency syndromes --- Virus-induced immunosuppression --- Immune System Disorders --- Disorder, Immune System --- Immune System Disorder
Choose an application
HIV is the leading cause of premature death in Thailand. Since the first case of AIDS was reported in 1984 more than one million Thais have been infected. The social, human and economic costs of this burden are enormous. The Thai government has shown a strong commitment to providing care and support to persons living with HIV/AIDS by launching the National Access to Care Program (NAPHA) in 2003, which provides for publicly financed antiretroviral therapy (ART) to all HIV-infected people. This book documents through interviews how ART has radically changed the lives of those living with HIV. In
Choose an application
Despite global progress in understanding the epidemiology of the human immunodeficiency virus (HIV), knowledge about the epidemic in the Middle East and North Africa (MENA) remains limited and subject to much controversy. In the more than 25 years since the discovery of HIV, no scientific study has provided a comprehensive, data-driven synthesis of the spread of HIV/AIDS (acquired immunodeficiency syndrome) in the region. Consequently, the effectiveness of policies, programs, and resources intended to address the spread of HIV/AIDS has been compromised. This report aims to fill the knowledge g
Choose an application
HIV Epidemics in the European Region: Vulnerability and Response provides a systematic review of the evidence on HIV vulnerability and response in all 53 countries of the World Health Organization's (WHO's) European Region, stretching from Iceland to the borders of China. The report focuses on key populations most at risk of HIV infection: people who inject drugs, sex workers, and men who have sex with men. It confirms that these populations are disproportionately affected by the growing HIV epidemic in Europe. Twenty-five percent of HIV diagnoses in Europe are associated with injecting drug u
Choose an application
Infectious diseases. Communicable diseases --- Caribbean area --- AIDS (Disease) --- Acquired immune deficiency syndrome --- Acquired immunodeficiency syndrome --- Acquired immunological deficiency syndrome --- HIV infections --- Immunological deficiency syndromes --- Virus-induced immunosuppression
Listing 1 - 10 of 69 | << page >> |
Sort by
|